Lupin gets FDA approval for Generic Actos

Lupin has received final approval for its Pioglitazone Tablets USP from the USFDA to market a generic version of Takeda Actos Tablets.


Approval granted!

Actos Tablets had annual US sales of US $236 million.

Lupin's Pioglitazone Tablets USP, 15 mg, 30 mg, and 45 mg are the AB-rated generic equivalents of Takeda's Actos Tablets 15 mg, 30 mg, and 45 mg and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email